Visudyne

Active Ingredient(s): Verteporfin
FDA Approved: * April 12, 2000
Pharm Company: * QLT
Category: Vision / Eye Health

Verteporfin (trade name Visudyne), a benzoporphyrin derivative, is a medication used as a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as the wet form of macular degeneration. Verteporfin accumulates in these abnormal blood vessels and, when stimulated by nonthermal red light with a wavelength of 689nm[1] in the presence of oxygen, produces highly reactive short-lived singlet oxygen and other reacti... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Visudyne 15 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0187-5600
Labeler:
Valeant Pharmaceuticals North America LLC
Visudyne 15 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 50236-001
Labeler:
Qlt Ophthalmics, Inc.